XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.25.2

Shareholders Equity | 9 Months Ended
--- | ---
Jun. 30, 2025
Shareholders Equity |
Shareholders' Equity | 13. Shareholders’ Equity Share-based Compensation Amended and Restated 2013 Incentive Stock Plan, as amended As of June 30, 2025, there were vested and unvested shares of restricted stock and stock options outstanding under the Company’s Amended and Restated 2013 Incentive Stock Plan, as amended (“Incentive Stock Plan”). The Incentive Stock Plan, as amended, provides for total shares available for restricted stock and stock options of 15,000 (7,500 restricted stock shares and 7,500 stock option shares). The Incentive Stock Plan authorizes the Compensation Committee of the Board of Directors to grant non-statutory stock options to employees. Vesting periods are established by the Compensation Committee at the time of grant. As of June 30, 2025, there were 6,817 shares available to be granted under the Plan (4,005 shares available for restricted stock grants and 2,812 shares available for non-qualified stock option grants). Restricted Stock The Company has an annual incentive compensation program (“AICP”) for its executives which is administered under the Company’s Incentive Stock Plan. The AICP includes a long-term incentive (“LTI”) compensation program in the form of restricted stock awards comprised of two components: one that vests based on future service only, and a second that vests based on future service and performance. Initial awards under both service-only and service plus performance-based components of the AICP LTI plan are determined based on financial performance measures for the immediately preceding fiscal year. The Company granted 48 shares of restricted stock under the AICP during the nine months ended June 30, 2025. Of the 48 shares granted, 8 were granted based on actual fiscal 2023 results and will cliff vest on December 1, 2026, the second anniversary from their date of grant, based on future service and performance. The remaining 40 future service and performance-based shares granted were based on fiscal 2022 results and will cliff vest on December 1, 2025, the first anniversary from their date of grant. These service plus performance-based restricted shares are subject to adjustment over their corresponding fiscal 2025 reporting period based on probability of achieving the fiscal 2025 financial targets set by the Company’s Board of Directors. The shares currently reported have been adjusted based on the probable outcome as compared to these financial targets. The final number of fiscal 2023 and 2022 service plus performance-based restricted shares granted will be determined once the actual financial performance of the Company is determined for fiscal 2025. Share-based compensation expense attributable to restricted stock was $53 and $78 for the three-month periods and $161 and $230 for the nine-month periods ended June 30, 2025 and 2024, respectively. As of June 30, 2025, there was approximately $143 of unrecognized compensation expense related to restricted stock outstanding and the weighted average remaining vesting period for those grants was 0.73 years. A summary of restricted stock activity is presented as follows:
|  | Number of Shares |  |  | Weighted Average Fair Value ($) |
Non-vested restricted stock outstanding as of September 30, 2024 |  |  | 906 |  |  |  | 0.71 |
Granted |  |  | 48 |  |  |  | 0.25 |
Vested |  |  | - |  |  |  | - |
Non-vested restricted stock outstanding as of December 31, 2024 |  |  | 954 |  |  |  | 0.69 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | - |  |  |  | - |
Non-vested restricted stock outstanding as of March 31, 2025 |  |  | 954 |  |  |  | 0.69 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | - |  |  |  | - |
Non-vested restricted stock outstanding as of June 30, 2025 |  |  | 954 |  |  |  | 0.69 |
Warrants The Company had no warrants outstanding as of June 30, 2025. As of September 30, 2024, the Company had 77 warrants outstanding with a weighted average exercise price per share of $2 and a weighted average remaining contractual life of 0.5 years. All outstanding warrants expired during the nine months ended June 30, 2025. Stock Options All stock options outstanding as of June 30, 2025 and September 30, 2024 were non-qualified stock options, had exercise prices equal to the market price on the date of grant, and had expiration dates ten years from the date of grant. The Company granted 1,550 stock options during the nine months ended June 30, 2025. The Company’s stock options generally vest on annual schedules during periods ranging from two to four years, although some options are fully vested upon grant. Share-based compensation expense attributable to stock options is recognized over their estimated remaining lives and was $124 and $71 for the three-month periods and $257 and $229 for the nine-month periods ended June 30, 2025 and 2024, respectively. As of June 30, 2025, there was approximately $547 of unrecognized compensation expense related to unvested stock options outstanding, and the weighted average remaining vesting period for those options was 2.95 years. A summary of stock option activity is presented as follows:
|  | Number of Shares |  |  | Weighted Average Exercise Price per share ($) |  |  | Weighted Average Fair Value per share ($) |  |  | Weighted Average Remaining Contractual Life (Years) |  |  | Total Intrinsic Value of Options ($) |
Options outstanding as of September 30, 2024 |  |  | 3,351 |  |  |  | 1.17 |  |  |  | 0.93 |  |  |  | 7.08 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | (153 | ) |  |  | 0.72 |  |  |  | 1.10 |  |  |  | - |  |  |  | - |
Options outstanding as of December 31, 2024 |  |  | 3,198 |  |  |  | 1.19 |  |  |  | 0.95 |  |  |  | 6.78 |  |  |  | - |
Granted |  |  | 1,150 |  |  |  | 0.23 |  |  |  | 0.19 |  |  |  | - |  |  |  | - |
Forfeited |  |  | (10 | ) |  |  | 0.59 |  |  |  | 0.49 |  |  |  | - |  |  |  | - |
Options outstanding as of March 31, 2025 |  |  | 4,338 |  |  |  | 0.93 |  |  |  | 0.75 |  |  |  | 7.41 |  |  |  | - |
Granted |  |  | 400 |  |  |  | 0.20 |  |  |  | 0.14 |  |  |  | - |  |  |  | - |
Forfeited |  |  | (51 | ) |  |  | 1.09 |  |  |  | 0.97 |  |  |  | - |  |  |  | - |
Options outstanding as of June 30, 2025 |  |  | 4,687 |  |  |  | 0.87 |  |  |  | 0.69 |  |  |  | 7.40 |  |  |  | - |
Exercisable as of September 30, 2024 |  |  | 2,293 |  |  |  | 1.43 |  |  |  | 1.13 |  |  |  | 6.38 |  |  |  | - |
Exercisable as of June 30, 2025 |  |  | 3,000 |  |  |  | 1.15 |  |  |  | 0.91 |  |  |  | 6.53 |  |  |  | - |
Share Repurchase Program On April 27, 2023, the Company’s Board of Directors approved a share repurchase program authorizing the Company to purchase up to an aggregate of $20 million of the Company’s currently outstanding shares of common stock. The share repurchase program continued through December 31, 2023. The repurchase program did not obligate the Company to repurchase any number of shares of common stock. The share repurchase program was conducted in accordance with Rules 10b-5 and 10b-18 of the Securities Exchange Act of 1934, as amended. Subject to applicable rules and regulations, shares of common stock were purchased from time to time in the open market transactions and in amounts the Company deemed appropriate, based on factors such as market conditions, legal requirements, and other business considerations. The Company repurchased 2,717 shares of its common stock under program during the nine-month period ended June 30, 2024, at a net cost of $1,575. Upon conclusion of the share repurchase program, as of December 31, 2023, the Company repurchased 6,129 shares in aggregate (accounting for approximately 5.4% of our issued and outstanding common shares immediately prior to the program).

X
- References No definition available. + Details
Name: | job_ShareholdersEquityAndShareBasedCompensationAbstract
Namespace Prefix: | job_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration